BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 37949037)

  • 1. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Ying C; Liu CF; Guo DQ; Du ZR; Wei YJ
    Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting value of white cell count and total bilirubin on clinical outcomes in patients with ST-elevation myocardial infarction following percutaneous coronary intervention: a cohort study.
    Tuxun M; Zhao Q; Xiang Y; Liu F; Shan CF; Zhou XR; Song N; Waisiding A; Zhang XH; Aihemaiti G; Yang YN; Li XM
    BMJ Open; 2020 Feb; 10(2):e031227. PubMed ID: 32075822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L; Wang Y; Wang W; Wang Z
    Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y; Peng Z
    Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
    Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Total Bilirubin and Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Chung SR; Yang TH; Shin HC; Jin HY; Seo JS; Jang JS; Kim DK; Kim DS; Seo GW; Song PS; Kim DK; Kim KH; Seol SH; Kim DI; Cho YK; Yoon HJ; Nam CW; Hur SH; Kim U; Park JS; Kim YJ
    Circ J; 2016 May; 80(6):1437-44. PubMed ID: 27151334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of CHA
    Sun Y; Ren J; Wang W; Wang C; Li L; Yao H
    Clin Cardiol; 2023 Aug; 46(8):950-957. PubMed ID: 37430484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
    Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective study.
    Chen Y; Jiang D; Tao H; Ge P; Duan Q
    BMC Cardiovasc Disord; 2022 Oct; 22(1):434. PubMed ID: 36199038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction.
    Chen Y; Gao YF; Wang YF; Wang CJ; Du Y; Ding YH
    Clin Interv Aging; 2022; 17():1687-1695. PubMed ID: 36467316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
    Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
    Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Pusuroglu H; Cakmak HA; Akgul O; Erturk M; Surgit O; Akkaya E; Bulut U; Yildirim A
    Rev Port Cardiol; 2015 Oct; 34(10):597-606. PubMed ID: 26387826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: A retrospective study.
    Deng J; Wang X; Shi Y; Zhao X; Han Y
    J Interv Cardiol; 2018 Feb; 31(1):33-40. PubMed ID: 28940388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.
    Tian C; Song J; He D; Wu J; Sun Z; Sun Z
    Int Heart J; 2018 Mar; 59(2):286-292. PubMed ID: 29563382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI.
    Chang X; Zhang S; Zhang M; Wang H; Fan C; Gu Y; Wei J; Qiu C
    Lipids Health Dis; 2018 Oct; 17(1):234. PubMed ID: 30309366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic value of myocardial infarct size measured by cardiovascular magnetic resonance in patients with acute ST-segment elevation myocardial infarction].
    Zhang SR; Li RX; Jiao YD; Zhang N; Duan WL; Sun ZJ; Sun ZQ
    Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):751-756. PubMed ID: 34304452
    [No Abstract]   [Full Text] [Related]  

  • 20. Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI.
    Celik T; Kaya MG; Akpek M; Yarlioglues M; Sarli B; Topsakal R; Gibson CM
    Angiology; 2014 Mar; 65(3):198-204. PubMed ID: 23378197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.